Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Natural Alternatives International Inc | NAII | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
6.25 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 5.06 - 8.81 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 6.25 | USD |
Natural Alternatives International Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
38.06M | 6.09M | - | 155.44M | 2.52M | 0.41 | 15.09 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Natural Alternatives News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NAII Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.40 | 6.65 | 6.15 | 6.25 | 3,497 | -0.15 | -2.34% |
1 Month | 6.95 | 6.95 | 6.15 | 6.51 | 4,421 | -0.70 | -10.07% |
3 Months | 6.12 | 7.0499 | 5.59 | 6.18 | 5,123 | 0.13 | 2.12% |
6 Months | 6.14 | 7.37 | 5.59 | 6.25 | 5,167 | 0.11 | 1.79% |
1 Year | 8.81 | 8.81 | 5.06 | 6.56 | 7,082 | -2.56 | -29.06% |
3 Years | 15.26 | 19.93 | 5.06 | 12.02 | 13,579 | -9.01 | -59.04% |
5 Years | 13.16 | 19.93 | 4.75 | 11.72 | 14,580 | -6.91 | -52.51% |
Natural Alternatives Description
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing, and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment primarily includes royalty income from its license and supply agreements associated with the sale. |